OverviewSuggest Edit

Cytek Biosciences is a cell analysis solutions company developing cell analysis tools. It offers the Aurora and Northern Lights systems, the full-spectrum flow cytometers that deliver cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. The applications of the technology include drug discovery, genomics, immuno-oncology, immunoprofiling, infectious diseases, inflammatory diseases, multi-site standardization.
TypePublic
Founded1992
HQFremont, CA, US
Websitecytekbio.com
Employee Ratings3

Latest Updates

Employees (est.) (Mar 2021)390
Share Price (Nov 2021)$23.6(+4%)
Cybersecurity ratingCMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Cytek Biosciences

Wenbin Jiang

Wenbin Jiang

CEO and Chairman of the Board
Ming Yan

Ming Yan

CTO
Valerie Barnett

Valerie Barnett

General Counsel and Corporate Secretary
Patrik Jeanmonod

Patrik Jeanmonod

CFO
Raymond A. Lannigan

Raymond A. Lannigan

VP of Global Sales & Service
Maria Jaimes

Maria Jaimes

VP of Applications
Show more

Cytek Biosciences Office Locations

Cytek Biosciences has offices in Fremont, Bethesda, Shanghai, Tokyo and in 1 other location
Fremont, CA, US (HQ)
46107 Landing Pkwy
Bethesda, MD, US
4520 East West Highway, Suite 615
Shanghai, CN
560 Shengxia Road, Suite 603
Tokyo, JP
2-9-1 Ikenohata, Taito-ku
Amsterdam, NL
Amstelveenseweg 638
Amsterdam, NL
Paasheuvelweg 25, tower c5
Show all (6)

Cytek Biosciences Financials and Metrics

Cytek Biosciences Revenue

Market capitalization (12-Nov-2021)

3.0b

Closing stock price (12-Nov-2021)

23.6
Cytek Biosciences's current market capitalization is $3 b.
Show all financial metrics

Cytek Biosciences Cybersecurity Score

Cybersecurity ratingPremium dataset

C

71/100

SecurityScorecard logo

Cytek Biosciences Online and Social Media Presence

Embed Graph

Cytek Biosciences News and Updates

Cytek Biosciences Acquires Tonbo Biosciences’ Cell Analysis Business

FREMONT, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that it has acquired the cell analysis business of Tonbo Biosciences™, which includes an extensive portfolio of life science research reagents rela…

Cytek Biosciences to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

FREMONT, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today announced the company will be participating in the Morgan Stanley 19th Annual Global Healthcare Conference.

Cytek Biosciences Reports Second Quarter 2021 Financial Results

FREMONT, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported financial results for the second quarter ended June 30, 2021.

Cytek Biosciences Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

FREMONT, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, announced today that the underwriters of its previously announced initial public offering, which closed on July 27, 2021, have exer…

Cytek Biosciences Announces Closing of Its Initial Public Offering

FREMONT, Calif., July 27, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, announced today the closing of its initial public offering of an aggregate of 14,564,635 shares of its common stock at a price to t…

Cytek Biosciences Announces Pricing of Its Initial Public Offering

FREMONT, Calif., July 22, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, announced today the pricing of its initial public offering of an aggregate of 16,749,330 shares of its common stock at a price to t…
Show more

Cytek Biosciences Frequently Asked Questions

  • When was Cytek Biosciences founded?

    Cytek Biosciences was founded in 1992.

  • Who are Cytek Biosciences key executives?

    Cytek Biosciences's key executives are Wenbin Jiang, Ming Yan and Valerie Barnett.

  • How many employees does Cytek Biosciences have?

    Cytek Biosciences has 390 employees.

  • Who are Cytek Biosciences competitors?

    Competitors of Cytek Biosciences include Becton Dickinson, Fluidigm and Thermo Fisher Scientific.

  • Where is Cytek Biosciences headquarters?

    Cytek Biosciences headquarters is located at 46107 Landing Pkwy, Fremont.

  • Where are Cytek Biosciences offices?

    Cytek Biosciences has offices in Fremont, Bethesda, Shanghai, Tokyo and in 1 other location.

  • How many offices does Cytek Biosciences have?

    Cytek Biosciences has 6 offices.